What are the steps to initiate a Diabetic Ketoacidosis (DKA) protocol?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 30, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Diabetic Ketoacidosis (DKA) Protocol Implementation

To initiate a DKA protocol, begin with aggressive fluid resuscitation with 0.9% saline at 15-20 ml/kg/hr for the first hour, followed by insulin therapy only after initial fluid resuscitation is complete. 1

Initial Assessment and Diagnosis

  • Confirm DKA diagnosis with:

    • Blood glucose >250 mg/dl
    • Venous pH <7.3
    • Bicarbonate <15 mEq/l
    • Moderate ketonuria or ketonemia 2, 1
  • Obtain STAT laboratory tests:

    • Blood glucose
    • Venous blood gases
    • Electrolytes
    • Blood urea nitrogen
    • Creatinine
    • Calcium
    • Phosphorous
    • Urinalysis 2

Step-by-Step DKA Protocol

1. Fluid Resuscitation (First Priority)

  • Begin with 0.9% saline at 15-20 ml/kg/hr during the first hour 1
  • Continue fluid resuscitation based on hemodynamic status
  • For pediatric patients: 1.5 times the 24-hour maintenance requirements (5 ml/kg/hr) for smooth rehydration; do not exceed twice the maintenance requirement 2

2. Insulin Therapy (Start AFTER initial fluid resuscitation)

  • Important: Check potassium level before starting insulin - delay insulin if K+ <3.3 mEq/l to avoid arrhythmias 2
  • For moderate-to-severe DKA:
    • Administer IV regular insulin bolus of 0.1 U/kg
    • Follow with continuous infusion at 0.1 U/kg/hr 1
  • For mild DKA:
    • Give "priming" dose of regular insulin 0.4-0.6 U/kg body weight
    • Half as IV bolus, half as subcutaneous/intramuscular injection
    • Then 0.1 U/kg/hr subcutaneously or intramuscularly 2
  • Target glucose reduction: 50-70 mg/dl per hour 1

3. Electrolyte Management

  • Potassium replacement:

    • Begin when serum K+ <5.5 mEq/l (if adequate urine output)
    • Add 20-30 mEq potassium (2/3 KCl and 1/3 KPO4) per liter of IV fluid 2
    • If significant hypokalemia present, start potassium replacement before insulin 2, 1
  • Bicarbonate therapy (generally not recommended unless severe acidosis):

    • pH <6.9: 100 mmol sodium bicarbonate in 400 ml sterile water at 200 ml/hr
    • pH 6.9-7.0: 50 mmol sodium bicarbonate in 200 ml sterile water at 200 ml/hr
    • pH >7.0: No bicarbonate needed 2, 1
  • Phosphate replacement:

    • Consider only for patients with cardiac dysfunction, anemia, respiratory depression, or serum phosphate <1.0 mg/dl 2, 1

4. Monitoring Protocol

  • Blood glucose: Every 1-2 hours
  • Serum electrolytes, BUN, creatinine: Every 2-4 hours
  • Venous pH and anion gap: Monitor to assess acidosis resolution 1
  • Continue monitoring for signs of hypoglycemia (sweating, drowsiness, dizziness, tremor) 3

5. Transition from IV to Subcutaneous Insulin

  • Transition when:
    • Blood glucose <200 mg/dl
    • Serum bicarbonate ≥18 mEq/l
    • Venous pH >7.3
    • Anion gap normalized
    • Patient hemodynamically stable 1
  • Calculate subcutaneous insulin dose based on average insulin infused during previous 12 hours 1

Common Pitfalls and Cautions

  • Never delay fluid resuscitation - it's the first priority in DKA management
  • Never start insulin before checking potassium levels - hypokalemia can lead to cardiac arrest 2
  • Avoid too rapid correction of glucose - target 50-70 mg/dl per hour to prevent cerebral edema 1
  • Don't rely on urinary ketone levels to monitor response to therapy - they may persist despite improvement 2
  • Monitor for signs of hypoglycemia during insulin therapy - be prepared to add dextrose to IV fluids when glucose <200 mg/dl while continuing insulin infusion 3
  • Watch for euglycemic DKA (blood glucose <250 mg/dl with ketoacidosis) - especially in patients on SGLT2 inhibitors or ketogenic diets 1, 4

By following this structured protocol, you can effectively manage DKA while minimizing complications and improving patient outcomes.

References

Guideline

Diabetic Ketoacidosis Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.